Return‐to‐work in lung transplant recipients: an Australian perspective
Internal Medicine Journal · 2025
DOI: 10.1111/imj.16641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Maitri Munsif und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Transplantation, Return to Work, Transplant Recipients. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Return‐to‐work (RTW) following lung transplant has been associated with increased quality of life, but little is known regarding the rates of and barriers to this in the Australian population.
Aims
We aimed to describe, characterise and determine predictors of return to work and social participation in Australian lung transplant recipients. We also sought to explore the relationship between return to work and quality of life.
Methods
We conducted a cross‐sectional questionnaire‐based study at the Alfred Hospital, Melbourne between October 2018 and August 2019. The questionnaire evaluated demographics, transplant history, respiratory parameters, employment history and social integration prior to and after lung transplantation.
Results
A total of 172 lung transplant recipients were included for analysis. The population was mostly male (56.5%), median age 61 years (interquartile range (IQR) 49.8–67.0) and median time from transplant 4 years (IQR 2–7). A total of 19.2% of patients were working at time of transplant, with 35.5% working after transplant representing an increase in workforce engagement of 84.8% ( P < 0.001). A total of 96% of those who returned to work reported an improvement in quality of life. Median time to RTW after transplant was 180 days (IQR 90–360). Multivariable analysis demonstrated an increased rate of RTW in younger recipients (odds ratio (OR) 0.94, 95% confidence interval (CI) 0.89–0.99, adjusted P = 0.029), at greater length of time after transplant (OR 1.09, 95% CI 0.99–1.19, P = 0.084), among those working at the time of transplant (OR 9.55, 95% CI 2.70–33.75, P < 0.001) and with higher socioeconomic status (OR 1.02, 95% CI 1.01–1.04, P = 0.009). Recipients with cystic fibrosis were more likely to RTW (65.8%) than those with other underlying conditions.
Conclusions
RTW should be encouraged in lung transplant recipients. Targeted supports and resources aimed at younger recipients may result in greater workforce engagement and overall outcomes after transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Maitri Munsif, Matthew Donnan, Gregory Snell, Kovi Levin, Miranda Paraskeva
Zitieren
APA
Munsif, M., Donnan, M., Snell, G., Levin, K., & Paraskeva, M. (2025). Return‐to‐work in lung transplant recipients: an Australian perspective. Internal Medicine Journal. https://doi.org/10.1111/imj.16641
Vancouver
Munsif M, Donnan M, Snell G, Levin K, Paraskeva M. Return‐to‐work in lung transplant recipients: an Australian perspective. Internal Medicine Journal. 2025. doi:10.1111/imj.16641
BibTeX
@article{Munsif2025,
author = {Munsif, Maitri and Donnan, Matthew and Snell, Gregory and Levin, Kovi and Paraskeva, Miranda},
title = {Return‐to‐work in lung transplant recipients: an Australian perspective},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.16641}
}
EUVIMED